Tentarix Biotherapeutics Emerges With $50 Million Series A
10/14/21, 1:00 PM
Location
Money raised
$50 million
Round Type
series a
Biotechnology company Tentarix Biotherapeutics LP today announced a $50 million Series A investment co-led by Versant Ventures and Samsara BioCapital.
Company Info
Location
san diego, california, united states
Additional Info
Tentarix’s mission is to develop first-in-class targeted, multifunctional, conditional therapies. The Company is focused on modalities that have cell specific function and has built a team that aims to transform biologics. For more information, please visit www.tentarix.com.